silybin has been researched along with Angiogenesis, Pathologic in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (61.54) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Mehrabani, M; Mohammadi, C; Najafi, R; Sameri, S | 1 |
Karas, D; Pivodová, V; Ulrichova, J; Valentová, K; Zahler, S | 1 |
Agarwal, R; Chittezhath, M; Deep, G; Raina, K; Rajamanickam, S; Singh, RP | 1 |
Agarwal, R; Raina, K; Sharma, G; Singh, RP | 1 |
Agarwal, R; Dwyer-Nield, LD; Malkinson, AM; Radcliffe, RA; Raina, K; Ramasamy, K; Redente, EF; Singh, RP; Tyagi, A | 1 |
Agarwal, R; Kaur, M; Rajamanickam, S; Singh, RP; Velmurugan, B | 1 |
Agarwal, R; Dwyer-Nield, LD; Hasebroock, KM; Malkinson, AM; Raina, K; Ramasamy, K; Serkova, NJ; Singh, RP; Tyagi, A | 1 |
Agarwal, R; Nambiar, D; Prajapati, V; Singh, RP | 1 |
Agarwal, C; Agarwal, R; Dhanalakshmi, S; Singh, RP | 1 |
Agarwal, R; Chittezhath, M; Deep, G; Dwyer-Nield, LD; Kaur, M; Malkinson, AM; Singh, RP | 1 |
Agarwal, C; Agarwal, R; Dhanalakshmi, S; Gu, M; Singh, RP | 1 |
Agarwal, R; Mohan, S; Sharma, G; Singh, RP; Tyagi, A | 1 |
Agarwal, R; Gu, M; Singh, RP | 1 |
13 other study(ies) available for silybin and Angiogenesis, Pathologic
Article | Year |
---|---|
Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Mice; Neovascularization, Pathologic; Silybin | 2021 |
Topics: Angiogenesis Inhibitors; Cell Cycle; Cell Proliferation; Endothelial Cells; Esters; Gallic Acid; Humans; MAP Kinase Signaling System; Microtubules; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Silybin; Silymarin; Structure-Activity Relationship | 2016 |
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Topics: Adenocarcinoma; Animals; Antioxidants; Apoptosis; Biomarkers, Tumor; Blotting, Western; Body Weight; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blotting, Western; Cadherins; Cell Proliferation; Disease Progression; Immunohistochemistry; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Silybin; Silymarin; Vimentin | 2008 |
Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Proliferation; Cytokines; Enzyme-Linked Immunosorbent Assay; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Macrophages; Male; Mice; Microvessels; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor | 2009 |
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Topics: Adenomatous Polyposis Coli; Animals; Antioxidants; Apoptosis; beta Catenin; Cell Growth Processes; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Intestinal Polyps; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Silybin; Silymarin; Transcriptional Activation | 2010 |
Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
Topics: Animals; Anticarcinogenic Agents; Cell Proliferation; Down-Regulation; Gene Deletion; Intermediate Filament Proteins; Lung; Lung Neoplasms; Male; Mice; Mice, Knockout; Neovascularization, Pathologic; Nerve Tissue Proteins; Nestin; NF-kappa B; Nitric Oxide Synthase Type II; Silybin; Silymarin; STAT3 Transcription Factor; Tumor Burden; Urethane; Vascular Endothelial Growth Factor Receptor-2; X-Ray Microtomography | 2011 |
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Humans; Male; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2013 |
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Apoptosis; Biological Assay; Cell Cycle; Cell Movement; Cells, Cultured; Collagen; Down-Regulation; Drug Combinations; Endothelium, Vascular; Humans; Inhibitor of Apoptosis Proteins; Laminin; Membrane Potentials; Microtubule-Associated Proteins; Mitochondria; Neoplasm Proteins; Neovascularization, Pathologic; NF-kappa B; Protein Serine-Threonine Kinases; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Silybin; Silymarin; Survivin | 2005 |
Effect of silibinin on the growth and progression of primary lung tumors in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinogens; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Disease Models, Animal; Fibroblast Growth Factor 2; Immunohistochemistry; Inflammation; Lung Neoplasms; Mice; Microcirculation; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Silybin; Silymarin; Urethane; Vascular Endothelial Growth Factor A | 2006 |
Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice.
Topics: Animals; Antioxidants; Cell Growth Processes; Cell Nucleus; Cell Transformation, Neoplastic; Cyclooxygenase 2; Female; Inflammation; Mice; Mice, Hairless; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Silybin; Silymarin; Skin; Skin Neoplasms; STAT3 Transcription Factor; Ultraviolet Rays | 2007 |
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Microtubule-Associated Proteins; Neovascularization, Pathologic; Repressor Proteins; Silybin; Silymarin; Survivin; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
Topics: Animals; Antioxidants; Apoptosis; Cell Growth Processes; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Enzyme Activation; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Silybin; Silymarin; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |